FDA Approved: LEUPROLIDE ACETATE — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved the Leuprolide acetate original application (ANDA213829) for a generic version, issued to NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)

Snippet

ORIG AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)